UMD researchers have discovered key mechanisms in gene regulation that could improve the design of RNA-based medicines.

SALT LAKE CITY, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic and genomic tumor ...

The largest study to date to analyze millions of both genetic and patient records on the long-term health conditions of later ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...

Last week, Founders Fund partner Delian Asparouhov realized he hadn’t checked on his genetics in a while. He clicked open a ...

Factors like nutrition and muscle strength and size are all involved when it comes to your running speed, and your genetics ...

Opus Genetics (NASDAQ:IRD – Get Free Report) is one of 1,064 public companies in the “Pharmaceutical preparations” industry, but how does it weigh in compared to its rivals? We will compare Opus ...

A new Yale study provides a fuller picture of the genetic changes that shaped the evolution of the human brain, and how the ...

Cranswick, a U.K.-based poultry and pork producer, acquired the entire issued share capital of JSR Genetics Limited from JSR ...

Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic and genomic tumor testing and precision medicine, and INTERLINK Care Management, Inc. announced ...

In a recent study, Mass General Brigham researchers demonstrated that through low-cost genetic samples that can be obtained ...